Improving Health Technology Access in Australia: Final Review Recommendations

The Australian Government’s Health Technology Assessment (HTA) Policy and Methods Review proposes critical reforms to modernize and futureproof Australia’s approach to funding and approving health technologies. The review emphasizes equitable, timely, and transparent access to therapies for all Australians, particularly underrepresented groups such as First Nations people and pediatric patients.

Key recommendations include:

• Equity in Access: Establish a First Nations Advisory Committee and mandate that sponsors of HTA submissions include assessments of their impacts on First Nations health outcomes.

• Streamlined Pathways: Simplify processes for approving vaccines, therapies for rare diseases, and high-cost technologies to reduce wait times.

• Transparency: Enhance public understanding by publishing plain-language summaries and improving stakeholder engagement.

• Data Utilization: Develop robust real-world data systems to inform decision-making and track health technology impacts post-implementation.

• Workforce Expansion: Build capacity within the HTA system to handle the growing complexity and volume of submissions, especially for innovative therapies like gene and cell treatments.

These reforms are vital for maintaining Australia’s world-class healthcare system, ensuring timely access to transformative technologies, and addressing health inequities.

Read the full report here, and follow InGeNA for updates on genomics and health technology innovations in Australia.